Iterum Therapeutics plc (NASDAQ:ITRM), a pharmaceutical company with a market capitalization of $53.43 million, has reported a regulatory compliance issue with the Nasdaq Stock Market. According to ...
SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...
Q4 2024 Earnings Call Transcript February 13, 2025 Datadog, Inc. beats earnings expectations. Reported EPS is $0.49, ...
Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...
Hosted on MSN4h
Wall Street ends mixed; Nvidia lifts NasdaqWall Street stocks ended mixed on Friday, with Nvidia climbing and Microsoft dipping, while Treasury yields declined a day ...
Q4 2024 Earnings Call Transcript February 13, 2025 Euronet Worldwide, Inc. beats earnings expectations. Reported EPS is $2.08 ...
Q4 2024 Earnings Call Transcript February 13, 2025 Chris Uchida: Good morning, and welcome to the Palomar Holdings, Inc.
Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Ladies and gentlemen, thank you for standing by. My name is ...
Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...
Q4 2024 Earnings Call Transcript February 12, 2025 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.08, ...
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript February 12, 2025 Anavex Life Sciences Corp. beats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback